(AMSC) American Superconductor - Overview
Stock: Gridtec, Windtec, D-VAR, ActiVAR, ArmorVAR
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 75.9% |
| Relative Tail Risk | -11.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -20.07 |
| Character TTM | |
|---|---|
| Beta | 2.283 |
| Beta Downside | 2.170 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.86% |
| CAGR/Max DD | 1.11 |
Description: AMSC American Superconductor January 13, 2026
American Superconductor Corp. (NASDAQ: AMSC) delivers megawatt-scale power-resiliency solutions through two operating segments – Grid and Wind – under the Gridtec Solutions and Windtec Solutions brands.
The Grid segment supplies utilities and industrial customers with transmission-planning services, D-VAR and actiVAR reactive-compensation hardware, and ship-protection systems. Its product mix targets congestion mitigation, voltage control, and power-quality improvement for both AC transmission networks and naval platforms.
The Wind segment licenses high-power (≥ 2 MW) turbine drivetrain designs and provides associated power-electronics, software control, and engineering support to turbine manufacturers worldwide.
Key market drivers include the U.S. Infrastructure Investment and Jobs Act, which earmarks roughly $65 billion for grid modernization, and the accelerating global renewable-energy build-out (≈ 12 % YoY new capacity in 2023). These trends underpin demand for AMSC’s voltage-control and grid-integration technologies.
Recent financial metrics (FY 2023) show a $70 million revenue base with a + 15 % year-over-year increase in backlog, reflecting growing orders for D-VAR systems in North America. The company’s gross margin has hovered around 30 %, but remains sensitive to the timing of large utility contracts.
Given the capital-intensive nature of grid upgrades and the competitive landscape (e.g., Siemens, ABB), AMSC’s upside hinges on winning multi-year utility contracts and expanding its Windtec licensing footprint in emerging markets.
For a deeper quantitative view, you may find ValueRay’s AMSC dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 130.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -5.04 > 1.0 |
| NWC/Revenue: 72.67% < 20% (prev 50.97%; Δ 21.70% < -1%) |
| CFO/TA 0.03 > 3% & CFO 20.2m > Net Income 130.5m |
| Net Debt (-129.7m) to EBITDA (23.3m): -5.58 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.9m) vs 12m ago 16.84% < -2% |
| Gross Margin: 30.59% > 18% (prev 0.28%; Δ 3032 % > 0.5%) |
| Asset Turnover: 54.26% > 50% (prev 63.88%; Δ -9.61% > 0%) |
| Interest Coverage Ratio: -5.95 > 6 (EBITDA TTM 23.3m / Interest Expense TTM -2.82m) |
Altman Z'' -7.52
| A: 0.28 (Total Current Assets 325.0m - Total Current Liabilities 122.0m) / Total Assets 719.5m |
| B: -1.29 (Retained Earnings -931.3m / Total Assets 719.5m) |
| C: 0.03 (EBIT TTM 16.8m / Avg Total Assets 514.9m) |
| D: -5.12 (Book Value of Equity -935.2m / Total Liabilities 182.7m) |
| Altman-Z'' Score: -7.52 = D |
Beneish M -2.01
| DSRI: 1.01 (Receivables 62.6m/44.1m, Revenue 279.4m/198.2m) |
| GMI: 0.90 (GM 30.59% / 27.55%) |
| AQI: 2.10 (AQ_t 0.42 / AQ_t-1 0.20) |
| SGI: 1.41 (Revenue 279.4m / 198.2m) |
| TATA: 0.15 (NI 130.5m - CFO 20.2m) / TA 719.5m) |
| Beneish M-Score: -2.01 (Cap -4..+1) = BB |
What is the price of AMSC shares?
Over the past week, the price has changed by -5.85%, over one month by -8.39%, over three months by -22.93% and over the past year by -17.73%.
Is AMSC a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMSC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.3 | 103.5% |
| Analysts Target Price | 57.3 | 103.5% |
| ValueRay Target Price | 36.7 | 30.1% |
AMSC Fundamental Data Overview February 07, 2026
P/E Forward = 23.31
P/S = 4.6401
P/B = 2.2953
P/EG = -0.06
Revenue TTM = 279.4m USD
EBIT TTM = 16.8m USD
EBITDA TTM = 23.3m USD
Long Term Debt = 3.37m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 2.70m USD (from shortTermDebt, last quarter)
Debt = 11.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -129.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.11b USD (1.24b + Debt 11.4m - CCE 141.1m)
Interest Coverage Ratio = -5.95 (Ebit TTM 16.8m / Interest Expense TTM -2.82m)
EV/FCF = 69.06x (Enterprise Value 1.11b / FCF TTM 16.0m)
FCF Yield = 1.45% (FCF TTM 16.0m / Enterprise Value 1.11b)
FCF Margin = 5.73% (FCF TTM 16.0m / Revenue TTM 279.4m)
Net Margin = 46.70% (Net Income TTM 130.5m / Revenue TTM 279.4m)
Gross Margin = 30.59% ((Revenue TTM 279.4m - Cost of Revenue TTM 193.9m) / Revenue TTM)
Gross Margin QoQ = 30.66% (prev 31.03%)
Tobins Q-Ratio = 1.54 (Enterprise Value 1.11b / Total Assets 719.5m)
Interest Expense / Debt = 1.53% (Interest Expense 174.0k / Debt 11.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = 13.3m (EBIT 16.8m * (1 - 21.00%))
Current Ratio = 2.66 (Total Current Assets 325.0m / Total Current Liabilities 122.0m)
Debt / Equity = 0.02 (Debt 11.4m / totalStockholderEquity, last quarter 536.8m)
Debt / EBITDA = -5.58 (Net Debt -129.7m / EBITDA 23.3m)
Debt / FCF = -8.10 (Net Debt -129.7m / FCF TTM 16.0m)
Total Stockholder Equity = 352.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 25.34% (Net Income 130.5m / Total Assets 719.5m)
RoE = 37.04% (Net Income TTM 130.5m / Total Stockholder Equity 352.3m)
RoCE = 4.73% (EBIT 16.8m / Capital Employed (Equity 352.3m + L.T.Debt 3.37m))
RoIC = 4.57% (NOPAT 13.3m / Invested Capital 290.8m)
WACC = 14.21% (E(1.24b)/V(1.25b) * Re(14.33%) + D(11.4m)/V(1.25b) * Rd(1.53%) * (1-Tc(0.21)))
Discount Rate = 14.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 24.29%
[DCF Debug] Terminal Value 51.25% ; FCFF base≈18.6m ; Y1≈13.8m ; Y5≈7.98m
Fair Price DCF = 4.26 (EV 72.9m - Net Debt -129.7m = Equity 202.6m / Shares 47.6m; r=14.21% [WACC]; 5y FCF grow -30.75% → 2.90% )
[DCF Warning] FCF declining rapidly (-30.75%), DCF may be unreliable
EPS Correlation: 71.74 | EPS CAGR: 132.7% | SUE: 4.0 | # QB: 1
Revenue Correlation: 96.24 | Revenue CAGR: 29.45% | SUE: 1.90 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.25 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=3
EPS next Year (2027-03-31): EPS=1.11 | Chg30d=+0.040 | Revisions Net=+1 | Growth EPS=+32.8% | Growth Revenue=+24.5%